NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice

被引：0
|
作者：
Sahar Sadr-Momtaz
Maryam Aftabi
Emad Behboudi
Malihe Naderi
Anahita Hashemzadeh-Omran
Abdolvahab Moradi
机构：
[1] Golestan University of Medical Sciences,Department of Microbiology
[2] Khoy University of Medical Sciences,Department of Basic Sciences
[3] Golestan University of Medical Sciences,Infectious Disease Research Center
来源：
BMC Research Notes | / 16卷
关键词：
Vaccine; HPV; E6/E7/L1; Adjuvant; NSP4;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 18 条
  • [1] NSP4 as adjuvant for immunogenicity and design of effective therapeutic HPV16 E6/E7/L1 DNA vaccine in tumor-bearing and healthy C57BL/6 mice
    Sadr-Momtaz, Sahar
    Aftabi, Maryam
    Behboudi, Emad
    Naderi, Malihe
    Hashemzadeh-Omran, Anahita
    Moradi, Abdolvahab
    BMC RESEARCH NOTES, 2023, 16 (01)
  • [2] HPV16 E6/E7-based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
    Zhou, Kun
    Yuzhakov, Olga
    Behloul, Nouredine
    Wang, Dehua
    Bhagat, Lakshmi
    Chu, Dafeng
    Zhang, Xinyue
    Cheng, Xinwei
    Fan, Lusheng
    Huang, Xinyu
    Mirabella, Teodelinda
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [3] Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
    Tseng, Ssu-Hsueh
    Liu, Li
    Peng, Shiwen
    Kim, Jinhwi
    Ferrall, Louise
    Hung, Chien-Fu
    Wu, T. C.
    JOURNAL OF BIOMEDICAL SCIENCE, 2021, 28 (01)
  • [4] Control of Spontaneous HPV16 E6/E7 Expressing Oral Cancer in HLA-A2 (AAD) Transgenic Mice with Therapeutic HPV DNA Vaccine
    Ssu-Hsueh Tseng
    Li Liu
    Shiwen Peng
    Jinhwi Kim
    Louise Ferrall
    Chien-Fu Hung
    T. -C. Wu
    Journal of Biomedical Science, 28
  • [5] Brucella abortus RB51 lipopolysaccharide influence as an adjuvant on the therapeutic efficacy of HPV16 L1 and HPV16 E7 DNA vaccines
    Shirmohammadi, Masoumeh
    Soleimanjahi, Hoorieh
    Kianmehr, Zahra
    Karimi, Hesam
    Ardestani, Susan Kaboudanian
    IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 24 (02) : 92 - 97
  • [6] Antibody Response for L1, E6, E7 HPV 16, and HPV 18 Antigens in Tunisian Women with Cervical Cancer
    Achour, M.
    Zeghal, D.
    Kochbati, L.
    Kahla, S.
    Zouari, F.
    Maalej, M.
    Oueslati, R.
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2009, 30 (01) : 82 - 96
  • [7] Immunization with mutant HPV16 E7 protein inhibits the growth of TC-1 cells in tumor-bearing mice
    Li, Yan-Li
    Ma, Zhong-Liang
    Zhao, Yue
    Zhang, Jing
    ONCOLOGY LETTERS, 2015, 9 (04) : 1851 - 1856
  • [8] Antibody response for L1, E6 and E7 HPV 16 and HPV 18 antigens in Tunisian women with cervical cancer and controls
    Achour, M.
    Zeghal, D.
    Kochbati, L.
    Kahla, S.
    Zouari, F.
    Maalej, M.
    Oueslati, R.
    JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2008, 29 (03) : 266 - 280
  • [9] FLT3L and granulocyte macrophage colony-stimulating factor enhance the anti-tumor and immune effects of an HPV16 E6/E7 vaccine
    Ding, Zhenzhen
    Zhu, Hua
    Mo, Laiming
    Li, Xiangyun
    Xu, Rui
    Li, Tian
    Zhao, Liang
    Ren, Yi
    Xu, Yunsheng
    Ou, Rongying
    AGING-US, 2019, 11 (24): : 11893 - 11904
  • [10] DNA vaccine encoding heat shock protein 60 co-linked to HPV 16 E6 and E7 tumor antigens generates more potent immunotherapeutic effects than respective E6 or E7 tumor antigens
    Huang, Chia-Yen
    Chen, Chi-An
    Lee, Chien-Nan
    Chang, Ming-Cheng
    Su, Yi-Ning
    Lin, Yi-Chun
    Hsieh, Chang-Yao
    Cheng, Wen-Fang
    GYNECOLOGIC ONCOLOGY, 2007, 107 (03) : 404 - 412
12